Nucleophosmin in Its Interaction with Ligands.

AML B23 acute myeloid leukemia cancer nucleophosmin protein–nucleic acids interactions protein–protein interactions

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Jul 2020
Historique:
received: 29 05 2020
revised: 07 07 2020
accepted: 08 07 2020
entrez: 16 7 2020
pubmed: 16 7 2020
medline: 18 2 2021
Statut: epublish

Résumé

Nucleophosmin (NPM1) is a mainly nucleolar protein that shuttles between nucleoli, nucleoplasm and cytoplasm to fulfill its many functions. It is a chaperone of both nucleic acids and proteins and plays a role in cell cycle control, centrosome duplication, ribosome maturation and export, as well as the cellular response to a variety of stress stimuli. NPM1 is a hub protein in nucleoli where it contributes to nucleolar organization through heterotypic and homotypic interactions. Furthermore, several alterations, including overexpression, chromosomal translocations and mutations are present in solid and hematological cancers. Recently, novel germline mutations that cause dyskeratosis congenita have also been described. This review focuses on NPM1 interactions and inhibition. Indeed, the list of NPM1 binding partners is ever-growing and, in recent years, many studies contributed to clarifying the structural basis for NPM1 recognition of both nucleic acids and several proteins. Intriguingly, a number of natural and synthetic ligands that interfere with NPM1 interactions have also been reported. The possible role of NPM1 inhibitors in the treatment of multiple cancers and other pathologies is emerging as a new therapeutic strategy.

Identifiants

pubmed: 32664415
pii: ijms21144885
doi: 10.3390/ijms21144885
pmc: PMC7402337
pii:
doi:

Substances chimiques

Ligands 0
NPM1 protein, human 0
Nuclear Proteins 0
Nucleic Acids 0
Proteins 0
Nucleophosmin 117896-08-9

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG2014-15197

Références

Molecules. 2020 Jan 22;25(3):
pubmed: 31979082
Biol Res. 2017 Jul 3;50(1):24
pubmed: 28673331
Genetics. 2006 Aug;173(4):1835-50
pubmed: 16751661
Leukemia. 2017 Apr;31(4):798-807
pubmed: 28111462
FASEB J. 2009 Aug;23(8):2360-5
pubmed: 19289604
Oncogene. 2014 May 29;33(22):2876-87
pubmed: 23831574
Cancer Cell. 2018 Sep 10;34(3):499-512.e9
pubmed: 30205049
Oncol Lett. 2016 Apr;11(4):2429-2432
pubmed: 27073492
Cancer Res. 2011 May 1;71(9):3296-305
pubmed: 21415166
Mol Cell Biol. 2006 May;26(10):3798-809
pubmed: 16648475
Mol Cell Biol. 2004 May;24(9):3703-11
pubmed: 15082766
J Biol Chem. 2008 Jun 6;283(23):15568-76
pubmed: 18420587
Nat Commun. 2018 Nov 29;9(1):5064
pubmed: 30498217
Mol Biol Cell. 2002 Jun;13(6):2016-30
pubmed: 12058066
Lung Cancer. 2017 May;107:14-21
pubmed: 27319334
FEBS J. 2018 Mar;285(5):828-831
pubmed: 29527821
BMC Bioinformatics. 2011 Aug 03;12:317
pubmed: 21812952
Anticancer Drugs. 2017 Aug;28(7):723-738
pubmed: 28471807
J Hematol Oncol. 2018 Jan 05;11(1):4
pubmed: 29304833
Mol Cell Biol. 2004 Feb;24(3):985-96
pubmed: 14729947
Mol Cell Biol. 2004 Nov;24(21):9327-38
pubmed: 15485902
Mol Cell Biol. 2005 Sep;25(17):7534-45
pubmed: 16107701
FEBS Lett. 2001 Oct 12;506(3):272-6
pubmed: 11602260
Biochem Biophys Res Commun. 2010 Jul 2;397(3):499-504
pubmed: 20515654
Best Pract Res Clin Haematol. 2010 Dec;23(4):457-61
pubmed: 21130407
J Mol Biol. 2001 Aug 3;311(1):41-55
pubmed: 11469856
APMIS. 2015 Jun;123(6):515-22
pubmed: 25907517
Exp Hematol Oncol. 2015 Mar 01;4:7
pubmed: 25745591
Biosci Biotechnol Biochem. 2002 Oct;66(10):2239-42
pubmed: 12450141
J Biol Chem. 2007 Jun 1;282(22):15981-94
pubmed: 17426024
Biochim Biophys Acta. 2014 Jun;1840(6):2050-9
pubmed: 24576674
Haematologica. 2016 Aug;101(8):951-8
pubmed: 27151989
Leuk Res. 2017 May;56:7-12
pubmed: 28152414
FEBS Lett. 2013 Jul 11;587(14):2254-9
pubmed: 23742937
Mol Carcinog. 2016 May;55(5):688-704
pubmed: 25865359
Clin Cancer Res. 2011 Oct 15;17(20):6490-9
pubmed: 21878537
Cancer Res. 2009 Oct 1;69(19):7653-61
pubmed: 19738048
FEBS Lett. 2014 Jun 27;588(14):2198-205
pubmed: 24857377
Bioessays. 2007 Jan;29(1):49-59
pubmed: 17187372
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4466-71
pubmed: 24616519
Oncogene. 2008 May 1;27(20):2858-67
pubmed: 18037965
Mol Cell. 2003 Nov;12(5):1151-64
pubmed: 14636574
Sci Rep. 2018 Mar 5;8(1):4008
pubmed: 29507312
Nat Rev Cancer. 2006 Jul;6(7):493-505
pubmed: 16794633
Cell Death Dis. 2016 Dec 1;7(12):e2497
pubmed: 27906185
Nucleic Acids Res. 1995 Oct 11;23(19):3974-9
pubmed: 7479045
Leukemia. 2006 Feb;20(2):319-21
pubmed: 16341035
Leukemia. 2013 Apr;27(5):1037-43
pubmed: 23183427
Oncotarget. 2017 Aug 3;8(56):95163-95175
pubmed: 29221119
Acta Pharmacol Sin. 2014 Jun;35(6):806-13
pubmed: 24902788
Angew Chem Int Ed Engl. 2016 Jan 26;55(5):1675-9
pubmed: 26679013
Br J Cancer. 2007 Feb 12;96(3):477-84
pubmed: 17245342
Mol Cell Biochem. 2008 Sep;316(1-2):163-7
pubmed: 18575815
Oncogene. 2009 Nov 26;28(47):4201-11
pubmed: 19734942
Curr Opin Cell Biol. 2019 Jun;58:50-60
pubmed: 30826604
Nat Cell Biol. 2005 Aug;7(8):823-30
pubmed: 16041368
Protein Sci. 2020 Jan;29(1):277-297
pubmed: 31710725
Oncogene. 2011 Jun 9;30(23):2595-609
pubmed: 21278791
Proteins. 2007 Nov 15;69(3):672-8
pubmed: 17879352
Nat Genet. 2019 Oct;51(10):1518-1529
pubmed: 31570891
J Biol Chem. 2012 Aug 3;287(32):26539-48
pubmed: 22707729
Biochem Cell Biol. 2016 Oct;94(5):419-432
pubmed: 27673355
Nat Commun. 2014 Nov 25;5:5437
pubmed: 25421715
EMBO Rep. 2009 Mar;10(3):231-8
pubmed: 19229283
Nat Cell Biol. 2008 Sep;10(9):1051-61
pubmed: 19160485
BMC Cancer. 2018 Aug 20;18(1):838
pubmed: 30126359
Cell Mol Life Sci. 2019 Nov;76(22):4511-4524
pubmed: 31338556
FEBS J. 2018 Mar;285(5):832-847
pubmed: 29283500
Mol Cell Biol. 2009 Sep;29(18):5115-27
pubmed: 19581289
Cancer. 2019 Jun 1;125(11):1789-1798
pubmed: 30933320
Leukemia. 2017 Jan;31(1):143-150
pubmed: 27211268
Biomolecules. 2020 Jan 16;10(1):
pubmed: 31963204
Biochemistry. 1989 Nov 28;28(24):9495-501
pubmed: 2482073
Ther Adv Hematol. 2020 Feb 3;11:2040620719899818
pubmed: 32071709
Blood. 2014 Dec 11;124(25):3768-71
pubmed: 25349176
J Biol Chem. 1994 Dec 9;269(49):30994-8
pubmed: 7527039
Blood. 2011 Sep 15;118(11):3096-106
pubmed: 21719597
Pac Symp Biocomput. 2012;:104-15
pubmed: 22174267
J Exp Clin Cancer Res. 2019 Jul 15;38(1):309
pubmed: 31307523
Ann Hematol. 2015 Feb;94(2):201-10
pubmed: 25242579
Nucleic Acids Res. 2013 Mar 1;41(5):3228-39
pubmed: 23328624
Cancer Res. 2010 Sep 1;70(17):6746-56
pubmed: 20713529
BMC Mol Biol. 2016 Aug 24;17(1):19
pubmed: 27553022
J Am Chem Soc. 2007 Nov 21;129(46):14444-51
pubmed: 17958425
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:61-79
pubmed: 28061688
Am J Clin Pathol. 2014 Mar;141(3):404-14
pubmed: 24515769
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Biochemistry. 2011 Apr 12;50(14):2780-9
pubmed: 21425800
Biomolecules. 2019 Mar 04;9(3):
pubmed: 30836703
Int J Biochem Cell Biol. 2019 Jun;111:52-62
pubmed: 31009764
Leukemia. 2016 Dec;30(12):2364-2372
pubmed: 27323910
Blood. 2006 Jun 1;107(11):4514-23
pubmed: 16455950
Cancer Res. 2016 Dec 15;76(24):7181-7193
pubmed: 27754848
Blood. 2010 Oct 28;116(17):3286-96
pubmed: 20606168
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
J Magn Reson. 2020 Jan;310:106646
pubmed: 31751897
J Biol Chem. 2010 Nov 26;285(48):37138-49
pubmed: 20858903
Leukemia. 2016 Jan;30(1):219-28
pubmed: 26265185
Biochem Res Int. 2011;2011:195209
pubmed: 21152184
Mol Cancer. 2014 Apr 01;13:75
pubmed: 24684778
Oncotarget. 2016 Jul 12;7(28):44821-44840
pubmed: 27058426
Blood. 2016 Aug 4;128(5):686-98
pubmed: 27288520
Biochemistry. 2001 Feb 27;40(8):2379-86
pubmed: 11327858
Nature. 2005 Sep 1;437(7055):147-53
pubmed: 16007073
Nature. 2014 Feb 20;506(7488):328-33
pubmed: 24522528
Blood Rev. 2018 May;32(3):167-183
pubmed: 29157973
J Biol Chem. 2008 Aug 22;283(34):23326-32
pubmed: 18511415
J Biochem. 2008 Apr;143(4):441-8
pubmed: 18024471
Cell Death Dis. 2014 Sep 25;5:e1427
pubmed: 25255220
Mol Cytogenet. 2014 Sep 25;7(1):63
pubmed: 25279000
Cancer Res. 2006 Mar 15;66(6):3044-50
pubmed: 16540653
Oncotarget. 2015 Aug 28;6(25):21443-51
pubmed: 26068981
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Mol Cell Biol. 2008 Dec;28(23):7050-65
pubmed: 18809582
Structure. 2004 Dec;12(12):2149-60
pubmed: 15576029
Mol Biol Cell. 2014 May;25(10):1641-52
pubmed: 24648491
Cell Biochem Biophys. 2006;46(1):79-90
pubmed: 16943625
Clin Cancer Res. 2020 Jan 1;26(1):54-60
pubmed: 31636097
Asian Pac J Trop Biomed. 2014 Jul;4(7):570-4
pubmed: 25183279
Oncogene. 2002 Sep 9;21(40):6170-4
pubmed: 12214246
Blood. 2019 Dec 19;134(25):2291-2303
pubmed: 31650162
Cell Cycle. 2017 Oct 18;16(20):1979-1991
pubmed: 28873013
J Recept Signal Transduct Res. 2016;36(2):167-72
pubmed: 26382555
J Biol Chem. 2014 Aug 1;289(31):21230-41
pubmed: 24952945
Biochem Biophys Res Commun. 2015 Oct 9;466(1):124-30
pubmed: 26343305
Blood Rev. 2013 Jan;27(1):13-22
pubmed: 23261068
J Clin Invest. 2018 Oct 1;128(10):4260-4279
pubmed: 30015632
J Microbiol. 2009 Dec;47(6):746-52
pubmed: 20127469
Tumour Biol. 2016 Jul;37(7):9967-77
pubmed: 26815508
Int J Hematol. 2019 Aug;110(2):150-160
pubmed: 30632059
J Cell Biol. 2008 Jul 14;182(1):19-26
pubmed: 18625840
Mol Biol Cell. 2006 Jun;17(6):2537-46
pubmed: 16540521
Oncogenesis. 2017 Sep 18;6(9):e379
pubmed: 28920929
Nat Commun. 2018 Feb 26;9(1):842
pubmed: 29483575
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Feb;34(1):58-61
pubmed: 22737721
J Biomed Sci. 2012 May 25;19:53
pubmed: 22631075
N Engl J Med. 2005 Jan 20;352(3):254-66
pubmed: 15659725
Mol Clin Oncol. 2013 Mar;1(2):215-219
pubmed: 24649149
Oncogene. 2008 Jul 10;27(30):4210-20
pubmed: 18345031
Biochem Biophys Res Commun. 2013 Jan 11;430(2):523-8
pubmed: 23232117
Blood. 2019 Dec 19;134(25):2281-2290
pubmed: 31650168
Cancer Detect Prev. 2006;30(6):481-90
pubmed: 17113241
Blood. 2012 Aug 30;120(9):1765-73
pubmed: 22677130
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5447-52
pubmed: 20212148
J Biol Chem. 2000 Aug 11;275(32):24451-7
pubmed: 10829026
Oncotarget. 2014 Jan 15;5(1):258-63
pubmed: 24473900
Elife. 2016 Feb 02;5:
pubmed: 26836305
Haematologica. 2016 Feb;101(2):e55-8
pubmed: 26471486
ACS Chem Biol. 2015 Mar 20;10(3):855-63
pubmed: 25531824
J Biol Chem. 1993 Jul 5;268(19):13930-4
pubmed: 8314759
Protein Sci. 1999 Apr;8(4):905-12
pubmed: 10211837
Bioorg Med Chem. 2015 Nov 15;23(22):7226-33
pubmed: 26602084
Mol Cell Biol. 2008 May;28(10):3114-26
pubmed: 18332108
Arch Pathol Lab Med. 2015 Oct;139(10):1308-13
pubmed: 26414475
Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1106-1114
pubmed: 25035215
PLoS One. 2015 Dec 01;10(12):e0143634
pubmed: 26624888
Mol Cell Biol. 1991 May;11(5):2567-75
pubmed: 2017166
Blood. 2017 Feb 16;129(7):823-831
pubmed: 27879258
Cell. 2016 Jun 16;165(7):1686-1697
pubmed: 27212236
Infect Disord Drug Targets. 2019;19(1):2-16
pubmed: 29589547
Oncogene. 1999 Jun 24;18(25):3716-24
pubmed: 10391679
Blood Rev. 2011 Nov;25(6):247-54
pubmed: 21724308
Br J Cancer. 2015 May 12;112(10):1636-43
pubmed: 25880012
J Biol Chem. 2014 Dec 12;289(50):34601-19
pubmed: 25349213
Microbiol Immunol. 2006;50(3):225-34
pubmed: 16547420
Haematologica. 2007 Apr;92(4):519-32
pubmed: 17488663
Cell Mol Biol Res. 1993;39(1):33-42
pubmed: 8287070
Cancer Lett. 2018 Jan 1;412:272-282
pubmed: 29111347
Protein Sci. 2013 May;22(5):545-56
pubmed: 23436734
Clin Cancer Res. 2016 Dec 15;22(24):6142-6152
pubmed: 27358488
Nucleic Acids Res. 2014 Jan;42(2):1180-95
pubmed: 24106084
J Clin Oncol. 2016 Dec;34(34):4094-4101
pubmed: 27507877
Sci Rep. 2015 Nov 12;5:16495
pubmed: 26559910
Int J Cancer. 2002 Aug 20;100(6):662-8
pubmed: 12209603
Oncotarget. 2017 Sep 30;8(52):90108-90122
pubmed: 29163814

Auteurs

Ilaria Cela (I)

Center for Advanced Studies and Technology (CAST), University of Chieti "G. d'Annunzio", Via Polacchi, 66100 Chieti, Italy.
Department of Medical, Oral and Biotechnological Sciences, University of Chieti "G. d'Annunzio", Via dei Vestini 31, 66100 Chieti, Italy.

Adele Di Matteo (A)

Institute of Molecular Biology and Pathology (IBPM) of the CNR, c/o "Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Roma, Italy.

Luca Federici (L)

Center for Advanced Studies and Technology (CAST), University of Chieti "G. d'Annunzio", Via Polacchi, 66100 Chieti, Italy.
Department of Medical, Oral and Biotechnological Sciences, University of Chieti "G. d'Annunzio", Via dei Vestini 31, 66100 Chieti, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH